Gary Loeb is EVP, General Counsel & Sec. of SANGAMO THERAPEUTICS, INC. Currently has a direct ownership of 83,238 shares of SGMO, which is worth approximately $94,058. The most recent transaction as insider was on Mar 23, 2021, when has been sold 17,524 shares (Common Stock) at a price of $13.15 per share, resulting in proceeds of $230,441. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 83.2K
0% 3M change
0% 12M change
Total Value Held $94,058

GARY LOEB Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 23 2021
SELL
Open market or private sale
$230,441 $13.15 p/Share
17,524 Reduced 17.39%
83,238 Common Stock
Mar 23 2021
BUY
Exercise of conversion of derivative security
$132,031 $11.02 p/Share
11,981 Added 10.63%
100,762 Common Stock
Feb 25 2021
SELL
Payment of exercise price or tax liability
$64,477 $11.19 p/Share
5,762 Reduced 11.4%
44,781 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
44,000 Added 33.14%
88,781 Common Stock

Also insider at

ISRG
INTUITIVE SURGICAL INC Healthcare
GL

Gary Loeb

EVP, General Counsel & Sec.
Brisbane, CA

Track Institutional and Insider Activities on SGMO

Follow SANGAMO THERAPEUTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMO shares.

Notify only if

Insider Trading

Get notified when an Sangamo Therapeutics, Inc insider buys or sells SGMO shares.

Notify only if

News

Receive news related to SANGAMO THERAPEUTICS, INC

Track Activities on SGMO